John Hancock Variable Insurance Trust - Health Sciences Trust (JAFKX)

Fund Assets	n/a
Expense Ratio	1.24%
Min. Investment	$0.00
Turnover	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	Annual
Ex-Dividend Date	Oct 23, 2025

Previous Close	21.33
YTD Return	n/a
1-Year Return	n/a
5-Year Return	n/a
52-Week Low	17.17
52-Week High	22.54
Beta (5Y)	n/a
Holdings	173
Inception Date	n/a

About JAFKX

John Hancock Variable Insurance Trust Health Sciences Trust Series II is an investment fund designed primarily for use within variable insurance products. Its central purpose is to provide investors with exposure to the healthcare and life sciences sectors by investing in equity securities of companies involved in health sciences, including pharmaceuticals, biotechnology, healthcare equipment, and services. The fund targets companies with durable and niche business models that are positioned to deliver high returns on capital, often focusing on mid- to large-cap firms with established market capitalizations and strong growth prospects. Employing a bottom-up stock selection approach, the fund's management emphasizes fundamental analysis to identify undervalued opportunities within the sector. Its role in the financial market is to offer diversification for investors seeking concentrated healthcare exposure within the broader context of insurance-linked investments, helping balance portfolio risk while capitalizing on innovation and demographic trends driving the health sciences industry. The fund is actively managed and reflects John Hancock’s commitment to sector-specific investment strategies within variable insurance trusts.

• Stock Exchange: Nasdaq
• Ticker Symbol: JAFKX
• Share Class: Series II
• Index: S&P 500 TR

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
JAFMX	Nav	0.99%
JEHSX	Series I	1.04%

Top 10 Holdings

48.29% of assets

Name	Symbol	Weight
Eli Lilly and Company - ELI LILLY and CO COMMON STOCK	LLY.US	14.30%
JOHNSON and JOHNSON COMMON STOCK USD1.0	JNJ.US	6.33%
UnitedHealth Group Incorporated - UNITEDHEALTH GROUP INC COMMON STOCK USD.01	UNH.US	5.95%
AbbVie Inc. - ABBVIE INC COMMON STOCK USD.01	ABBV.US	5.28%
Merck and Co. Inc. - MERCK + CO INC COMMON STOCK USD.5	MRK.US	4.21%
Gilead Sciences Inc. - GILEAD SCIENCES INC COMMON STOCK USD.001	GILD.US	2.95%
Thermo Fisher Scientific Inc. - THERMO FISHER SCIENTIFIC INC COMMON STOCK USD1.0	TMO.US	2.67%
Vertex Pharmaceuticals Incorporated - VERTEX PHARMACEUTICALS INC COMMON STOCK USD.01	VRTX.US	2.38%
Bristol-Myers Squibb Company - BRISTOL-MYERS SQUIBB CO COMMON STOCK USD.1	BMY.US	2.22%
ABBOTT LABORATORIES COMMON STOCK	ABT.US	2.00%

Dividend History

Ex-Dividend	Amount	Pay Date
Oct 23, 2025	$3.23399	Oct 24, 2025
Oct 24, 2024	$1.70757	Oct 25, 2024
Oct 24, 2023	$1.26206	Oct 25, 2023
Oct 25, 2022	$3.23984	Oct 26, 2022

Data Sources: Tiingo and Finnhub

Historical data is provided by Tiingo. Several fund data points are also provided by Finnhub.

Last checked:

Oct 16, 2026

Data Sources Report a data error